NCT02906553View on ClinicalTrials.gov

The Role of Nitric Oxide in Cognition in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
SchizophreniaPsychotic Disorders
Interventions
DRUG

Glyceryl Trinitrate

DRUG

Placebo

Trial Locations (1)

SW9 9NT

South London and Maudsley, London

All Listed Sponsors
collaborator

South London and Maudsley NHS Foundation Trust

OTHER

lead

King's College London

OTHER

NCT02906553 - The Role of Nitric Oxide in Cognition in Schizophrenia | Biotech Hunter | Biotech Hunter